| abstract |
As used herein, cancer tissue by applying one or more combinations of ablation-type fractional laser treatment, checkpoint inhibitors, and endosomal TLR agonists (e.g., TLR3, TLR7, TLR8, or TLR9 agonists) Methods that can be used to elicit a local immune response in and / or to increase the effectiveness of cancer treatment in a subject. |